Expertise in
1
conditions

Dr. Youn H. Kim

Anesthesiology
1301 N Rose Dr, 
Placentia, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
1
conditions
1301 N Rose Dr, 
Placentia, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Youn Kim is an Anesthesiologist in Placentia, California. Dr. Kim is highly rated in 1 condition, according to our data. His top areas of expertise are T-Cell Lymphoma, Small Lymphocytic Lymphoma (SLL), Discoid Lupus Erythematosus (DLE), and Arteriovenous Malformation.

His clinical research consists of co-authoring 234 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Anesthesiology
Licenses
Anesthesiology in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

1301 N Rose Dr, Placentia, CA 92870

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome
Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome
Enrollment Status: Recruiting
Publish Date: October 02, 2024
A Phase 1a/1b Dose Escalation and Expansion Trial of TTI-621, a Novel Biologic Targeting CD47, in Subjects With Relapsed or Refractory Hematologic Malignancies and Selected Solid Tumors
A Phase 1a/1b Dose Escalation and Expansion Trial of TTI-621, a Novel Biologic Targeting CD47, in Subjects With Relapsed or Refractory Hematologic Malignancies and Selected Solid Tumors
Enrollment Status: Terminated
Publish Date: May 10, 2024
Intervention Type: Drug
Study Drugs: TTI-621, Rituximab
Study Phase: Phase 1
A Phase II Trial of MK-3475 (Pembrolizumab) and Interferon Gamma 1-b Combination Immunotherapy in Patients With Previously Treated Mycosis Fungoides and Sezary Syndrome (Treatment Group 1) and in Patients With Advanced Synovial Sarcoma (Treatment Group 2)
A Phase II Trial of MK-3475 (Pembrolizumab) and Interferon Gamma 1-b Combination Immunotherapy in Patients With Previously Treated Mycosis Fungoides and Sezary Syndrome (Treatment Group 1) and in Patients With Advanced Synovial Sarcoma (Treatment Group 2)
Enrollment Status: Completed
Publish Date: October 25, 2023
Intervention Type: Other, Biological
Study Drugs: Interferon Gamma-1b, Pembrolizumab
Study Phase: Phase 2
A Phase II Study of Non-myeloablative Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) In Patients With Cutaneous T Cell Lymphoma
A Phase II Study of Non-myeloablative Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) In Patients With Cutaneous T Cell Lymphoma
Enrollment Status: Completed
Publish Date: May 11, 2023
Intervention Type: Drug, Radiation
Study Drugs: Anti-Thymocyte Globulin, Cyclosporine
Study Phase: Phase 2
A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients With the MF or SS Forms of Cutaneous T-Cell Lymphoma
A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients With the MF or SS Forms of Cutaneous T-Cell Lymphoma
Enrollment Status: Terminated
Publish Date: October 28, 2022
Intervention Type: Drug
Study Drug: Naloxone Hydrochloride Lotion
Study Phase: Phase 3
A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias
A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias
Enrollment Status: Completed
Publish Date: November 23, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 5 Less Clinical Trials

234 Total Publications

A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk Stratification.
A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk Stratification.
Journal: Blood
Published: April 16, 2025
Similar Doctors
Expertise in
1
conditions
Dr. Richard J. Kelly
Anesthesiology
Expertise in
1
conditions
Dr. Richard J. Kelly
Anesthesiology

Regents Of The University Of

101 The City Dr S, 
Orange, CA 
 (7.4 miles away)
714-456-7004
Languages Spoken:
English

Richard Kelly is an Anesthesiologist in Orange, California. Dr. Kelly is highly rated in 1 condition, according to our data. His top area of expertise is Paroxysmal Nocturnal Hemoglobinuria (PNH).

Expertise in
2
conditions
Dr. Neil K. Singla
Anesthesiology
Expertise in
2
conditions
Dr. Neil K. Singla
Anesthesiology
100 W. California Blvd, Unit 25, 
Pasadena, CA 
 (25.5 miles away)
626-397-2390
Languages Spoken:
English

Neil Singla is an Anesthesiologist in Pasadena, California. Dr. Singla is highly rated in 2 conditions, according to our data. His top areas of expertise are Opioid Induced Constipation and Abdominal Wall Surgery.

Expertise in
1
conditions
Dr. Joseph C. Chun
Anesthesiology
Expertise in
1
conditions
Dr. Joseph C. Chun
Anesthesiology
3030 W Olympic Blvd, #217, 
Los Angeles, CA 
 (28.7 miles away)
213-944-7123
Languages Spoken:
English
See accepted insurances

Joseph Chun is an Anesthesiologist in Los Angeles, California. Dr. Chun is highly rated in 1 condition, according to our data. His top area of expertise is Ptosis.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kim's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile